EUVIMEDEUVIMED entdecken
Open Access

EMC2 promotes breast cancer progression and enhances sensitivity to PDK1/AKT inhibition by deubiquitinating ENO1

Shihan Xiao, Shangxuan Jiang, Chengxu Wen, Han Wang, Wenxiang Nie, Jianguo Zhao, Bo Zhang

International Journal of Biological Sciences · 24.03.2025 · 21 (6) · 2629-2646

DOI: 10.7150/ijbs.109192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 24.03.2025. Verfasst von Shihan Xiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Proto-Oncogene Proteins c-akt, Tumor Suppressor Proteins, DNA-Binding Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsProto-Oncogene Proteins c-aktTumor Suppressor ProteinsDNA-Binding ProteinsMembrane ProteinsHumansFemaleCell Line, TumorCell ProliferationSignal TransductionAnimalsMiceProtein Serine-Threonine KinasesMCF-7 CellsDisease ProgressionUbiquitinationPyruvate Dehydrogenase Acetyl-Transferring KinasePhosphopyruvate HydrataseBiomarkers, Tumor

Stichwörter der Autor:innen

Breast cancerDeubiquitinationDrug sensitivityEMC2ENO1PDK1Scaffold

Substanzen

Proto-Oncogene Proteins c-aktTumor Suppressor ProteinsDNA-Binding ProteinsENO1 protein, humanPDK1 protein, humanMembrane ProteinsProtein Serine-Threonine KinasesPyruvate Dehydrogenase Acetyl-Transferring KinasePhosphopyruvate HydrataseBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Thyroid and Breast Surgery, Wuhan No. 1 Hospital, Wuhan, China.

Zitieren

APA

Xiao, S., Jiang, S., Wen, C., Wang, H., Nie, W., Zhao, J., & Zhang, B. (2025). EMC2 promotes breast cancer progression and enhances sensitivity to PDK1/AKT inhibition by deubiquitinating ENO1. International Journal of Biological Sciences, 21(6), 2629-2646. https://doi.org/10.7150/ijbs.109192

Vancouver

Xiao S, Jiang S, Wen C, Wang H, Nie W, Zhao J, et al. EMC2 promotes breast cancer progression and enhances sensitivity to PDK1/AKT inhibition by deubiquitinating ENO1. International Journal of Biological Sciences. 2025;21(6):2629-2646. doi:10.7150/ijbs.109192

BibTeX
@article{Xiao2025,
  author = {Xiao, Shihan and Jiang, Shangxuan and Wen, Chengxu and Wang, Han and Nie, Wenxiang and Zhao, Jianguo and Zhang, Bo},
  title = {EMC2 promotes breast cancer progression and enhances sensitivity to PDK1/AKT inhibition by deubiquitinating ENO1},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  volume = {21},
  number = {6},
  pages = {2629--2646},
  doi = {10.7150/ijbs.109192}
}
Kostenlos starten →